{"text": "This study thus demonstrates that the first administration of the recommended starting dose of << irbesartan >> induces a greater and longer lasting [[ Ang II receptor ]] blockade than that of valsartan and losartan in normotensive subjects.", "label": "INHIBITOR", "metadata": []}
{"text": "In humans, prolonged administration of the << beta 2-adrenoceptor >> agonist [[ terbutaline ]] leads to a desensitization of beta 2-adrenoceptor-mediated cardiovascular responses, which can be blunted by concomitant administration of the antianaphylactic drug ketotifen.", "label": "AGONIST", "metadata": []}
{"text": "In a double-blind, placebo-controlled, randomized design, nine healthy male volunteers received disodium cromoglycate (4 x 200 mg/day, p.o.) or placebo for 3 weeks with terbutaline (3 x 5 mg/day, p.o.) administered concomitantly during the last 2 weeks. beta 2-Adrenoceptor cardiovascular function was assessed by the increase in heart rate and reduction of diastolic blood pressure induced by an incremental intravenous infusion of the unselective << beta-adrenoceptor >> agonist [[ isoprenaline ]]; beta 1-adrenoceptor cardiovascular function was assessed by exercise-induced tachycardia.", "label": "AGONIST", "metadata": []}
{"text": "In addition, when << candesartan >> was given to conscious rats, the inhibitory effect on [[ Ang II ]]-induced blood pressure responses persisted during the 24-hour period despite nondetectable plasma concentrations of candesartan at 24 hours.", "label": "INDIRECT-DOWNREGULATOR", "metadata": []}
{"text": "At clinically relevant concentrations, << candesartan >> is an insurmountable and long-lasting antagonist of the vascular contractile responses to [[ Ang II ]].", "label": "INDIRECT-DOWNREGULATOR", "metadata": []}
{"text": "Concentration-response curves for the inhibition of monocyte COX-2 and platelet << COX-1 >> were obtained in vitro after the incubation of [[ meloxicam ]] with whole blood samples.", "label": "INHIBITOR", "metadata": []}
{"text": "The selective << 5-HT1A >> receptor antagonist, [[ WAY100,635 ]], slightly attenuated the (-)-pindolol-induced increase in DA and NAD levels, while the selective 5-HT1B antagonist, SB224,289, was ineffective.", "label": "ANTAGONIST", "metadata": []}
{"text": "Activation of << endothelial nitric oxide synthase >> (eNOS) results in the production of [[ nitric oxide ]] (NO) that mediates the vasorelaxing properties of endothelial cells.", "label": "PRODUCT-OF", "metadata": []}
{"text": "Here, we tested the hypothesis that 5-HT receptors mediate << eNOS >> activation by measuring agonist-stimulated [3H]L-citrulline ([[ [3H]L-Cit ]]) formation in BAEC cultures.", "label": "PRODUCT-OF", "metadata": []}
{"text": "We found that << 5-HT >> stimulated the conversion of [3H]L-arginine ([3H]L-Arg) to [3H]L-Cit, indicating [[ eNOS ]] activation.", "label": "ACTIVATOR", "metadata": []}
{"text": "We found that 5-HT stimulated the conversion of [3H]L-arginine ([3H]L-Arg) to << [3H]L-Cit >>, indicating [[ eNOS ]] activation.", "label": "PRODUCT-OF", "metadata": []}
{"text": "We found that 5-HT stimulated the conversion of [3H]L-arginine (<< [3H]L-Arg >>) to [3H]L-Cit, indicating [[ eNOS ]] activation.", "label": "SUBSTRATE", "metadata": []}
{"text": "These responses were effectively blocked by the 5-HT1B receptor antagonist, isamoltane, the 5-HT1B/5-HT2 receptor antagonist, methiothepin, and the << eNOS >> selective antagonists (0.01-10 microM): [[ L-Nomega -monomethyl-L-arginine ]] (L-NMMA) and L-N omega-iminoethyl-L-ornithine (L-NIO).", "label": "ANTAGONIST", "metadata": []}
{"text": "These responses were effectively blocked by the 5-HT1B receptor antagonist, isamoltane, the << 5-HT1B >>/5-HT2 receptor antagonist, [[ methiothepin ]], and the eNOS selective antagonists (0.01-10 microM): L-Nomega -monomethyl-L-arginine (L-NMMA) and L-N omega-iminoethyl-L-ornithine (L-NIO).", "label": "ANTAGONIST", "metadata": []}
{"text": "<< Losartan >> was the first, but by no means remained the only, [[ AT1 ]] receptor antagonist.", "label": "ANTAGONIST", "metadata": []}
{"text": "Among the current << AT1 >> receptor antagonists, the rank order of the relative binding affinities (highest affinity = 1) is: candesartan 1, telmisartan 10, E3174 (the active metabolite of losartan) 10, [[ tasosartan ]] 20, losartan 50, eprosartan 100 and the prodrug candesartan cilexetil 280.", "label": "ANTAGONIST", "metadata": []}
{"text": "Among the current << AT1 >> receptor antagonists, the rank order of the relative binding affinities (highest affinity = 1) is: candesartan 1, telmisartan 10, E3174 (the active metabolite of losartan) 10, tasosartan 20, losartan 50, [[ eprosartan ]] 100 and the prodrug candesartan cilexetil 280.", "label": "ANTAGONIST", "metadata": []}
{"text": "The << mNQO >> activity showed significantly higher affinity for NADH than NADPH as electron donors and catalyzed reduction of 2,6-dichlorophenolindophenol and [[ menadione ]].", "label": "SUBSTRATE", "metadata": []}
{"text": "The related piperidines ohmefentanyl and << sufentanil >> and the nonselective opioid receptor agonist etorphine were less potent [[ nociceptin receptor ]] agonists.", "label": "AGONIST", "metadata": []}
{"text": "The nonselective opioid receptor partial agonist buprenorphine and the nonselective << opioid receptor >> antagonist [[ (-)-quadazocine ]] exhibited pure antagonism at rat brain receptors, but displayed partial agonism at human ORL1 receptors.", "label": "ANTAGONIST", "metadata": []}
{"text": "<< Thymidylate synthase >> and thymidine kinase are key enzymes involved in the de novo and salvage pathways for [[ pyrimidine nucleotide ]] synthesis, respectively.", "label": "PRODUCT-OF", "metadata": []}
{"text": "Thymidylate synthase and << thymidine kinase >> are key enzymes involved in the de novo and salvage pathways for [[ pyrimidine nucleotide ]] synthesis, respectively.", "label": "PRODUCT-OF", "metadata": []}
{"text": "Thirty-week administration of UFT with or without << leucovorin >> markedly suppressed both colorectal carcinogenesis and tumor growth, resulted in the increase of [[ thymidylate synthase ]] inhibition and the decrease of thymidine kinase activity in the tumor cells.", "label": "INHIBITOR", "metadata": []}
{"text": "<< Ornithine decarboxylase >> (ODC) catalyses the first step in the synthesis of the polyamines putrescine, spermidine and [[ spermine ]].", "label": "PRODUCT-OF", "metadata": []}
{"text": "In << alpha(2A)-adrenoceptor >> transfected cells the rank order of agonist potency was [[ A-54741 ]] (mean pEC(50)=8.96)>dexmedetomidine (8.88)>UK-14304 (8.42)>B-HT 920 (7.05)>noradrenaline (6.92).", "label": "AGONIST", "metadata": []}
{"text": "In a physiological K(+) gradient, << TWIK-2 >> is half inhibited by 0.1 mm Ba(2+), [[ quinine ]], and quinidine.", "label": "INHIBITOR", "metadata": []}
{"text": "Initial in vitro studies utilizing HEP-G2 liver cells revealed that addition of eicosapentaenoic acid (<< EPA >>) blocked [[ Delta-5-desaturase ]] activity, the terminal enzymatic step in AA synthesis.", "label": "INHIBITOR", "metadata": []}
{"text": "Peroxisome proliferator-activated receptor alpha (<< PPARalpha >>) activators, [[ bezafibrate ]] and Wy-14,643, increase uncoupling protein-3 mRNA levels without modifying the mitochondrial membrane potential in primary culture of rat preadipocytes.", "label": "ACTIVATOR", "metadata": []}
{"text": "Since it has been proposed that UCP-3 could be involved in the regulation of the use of fatty acids as fuel substrates, the << UCP-3 >> induction achieved after bezafibrate and [[ Wy-14, 643 ]] treatment may indicate a higher oxidation of fatty acids, limiting their availability to be stored as triglycerides.", "label": "INDIRECT-UPREGULATOR", "metadata": []}
{"text": "The group treated with << pyridostigmine >> alone showed decreased plasma butyrylcholinesterase ([[ BChE ]]) activity (87% of control), whereas pyridostigmine plus exercise significantly decreased the BChE activity (79% of control), indicating an interactive effect of the combination.", "label": "INHIBITOR", "metadata": []}
{"text": "<< Creatine phosphokinase >> activity in plasma increased slightly (compared to control, [[ pyridostigmine ]] or exercise group) in mice treated with pyridostigmine plus exercise, which may be indicative of perturbation in the integrity of the skeletal muscle due to combination.", "label": "ACTIVATOR", "metadata": []}
{"text": "Clenbuterol was without effect on NGF mRNA levels in L929 cells, whereas << CB1093 >> caused significant increases in both [[ NGF ]] mRNA and protein levels in both 3T3 and L929 cells.", "label": "INDIRECT-UPREGULATOR", "metadata": []}
{"text": "This study demonstrates that << CB1093 >> and clenbuterol stimulate [[ NGF ]] levels in vitro and that AP-1 binding could be a commonality between the mechanism of NGF induction of these two compounds.", "label": "INDIRECT-UPREGULATOR", "metadata": []}
{"text": "RESULTS: << Halothane >> anesthesia reversibly inhibited metabolic [[ rhodopsin ]] regeneration and thus prevented rhodopsin from absorbing high numbers of photons during light exposure.", "label": "INDIRECT-DOWNREGULATOR", "metadata": []}
{"text": "Pemetrexed disodium (<< Alimta >>, LY231514) is a novel, multitargeted antifolate that inhibits thymidylate synthase, [[ dihydrofolate reductase ]], and glycinamide ribonucleotide formyl transferase.", "label": "INHIBITOR", "metadata": []}
{"text": "Nordihydroguaiaretic acid (<< NDGA >>) has been shown to inhibit both [[ 5-lipoxygenase ]] and ornithine decarboxylase and is active against several cancer cell lines and at least one mouse tumor model.", "label": "INHIBITOR", "metadata": []}
{"text": "The temporal profile of butyrylcholinesterase (BuChE) and in vitro << pralidoxime >>-reactivated [[ BuChE ]] was studied in a cohort of 25 organophosphate-poisoned patients to examine their relationship to the development of intermediate syndrome and to understand reasons for lack of efficacy of oxime treatment.", "label": "ACTIVATOR", "metadata": []}
{"text": "Schild analyses for the antagonists against brimonidine yielded regression lines with slopes of unity and functional antagonist potencies (pK(B)) for << BRL44408 >> (7.8), ARC 239 (5.8) and for prazosin (6.0) suggesting the presence of functional [[ alpha(2A)-adrenoceptors ]].", "label": "ANTAGONIST", "metadata": []}
{"text": "Schild analyses for the antagonists against brimonidine yielded regression lines with slopes of unity and functional antagonist potencies (pK(B)) for BRL44408 (7.8), ARC 239 (5.8) and for << prazosin >> (6.0) suggesting the presence of functional [[ alpha(2A)-adrenoceptors ]].", "label": "ANTAGONIST", "metadata": []}
{"text": "CONCLUSIONS: The << alpha(2)-adrenoceptor >> agonists [[ brimonidine ]], apraclonidine, and oxymetazoline are potent vasoconstrictors in the porcine ciliary artery.", "label": "AGONIST", "metadata": []}
{"text": "CONCLUSIONS: The << alpha(2)-adrenoceptor >> agonists brimonidine, apraclonidine, and [[ oxymetazoline ]] are potent vasoconstrictors in the porcine ciliary artery.", "label": "AGONIST", "metadata": []}
{"text": "<< Pemetrexed disodium >> (ALIMTA) is a novel antimetabolite that inhibits at least three folate-dependent enzymes, thymidylate synthase, dihydrofolate reductase, and [[ glycinamide ribonucleotide formyltransferase ]].", "label": "INHIBITOR", "metadata": []}
{"text": "We tested the new orally active nonpeptidic << renin >> inhibitor SPP100 ([[ Aliskiren ]], an octanamide with a 50% inhibitory concentration [IC50] in the low nanomolar range) in 18 healthy volunteers on a constant 100 mmol/d sodium diet using a double-blind, 3-way crossover protocol.", "label": "INHIBITOR", "metadata": []}
{"text": "Inhibition was still marked and significant after repeated dosing with maximal decreases in << Ang II >> levels by 89% and 75% on Days 1 and 8, respectively, when the highest dose of [[ Aliskiren ]] was compared with placebo.", "label": "INDIRECT-DOWNREGULATOR", "metadata": []}
{"text": "The earliest known << AChE >> inhibitors, namely, physostigmine and [[ tacrine ]], performed poorly in clinical trials (e.g., poor oral activity, brain penetration, and hepatotoxic liability).", "label": "INHIBITOR", "metadata": []}
{"text": "<< Donepezil hydrochloride >> inaugurates a new class of [[ AChE ]] inhibitors with longer and more selective action and with manageable adverse effects.", "label": "INHIBITOR", "metadata": []}
{"text": "A recent study showed that << anastrozole >>, an [[ aromatase ]] inhibitor, is as effective or even superior to tamoxifen when used as a first-line therapy.", "label": "INHIBITOR", "metadata": []}
{"text": "Chronic treatment with the NET inhibitor, << desipramine >> (DMI), reduced [[ NET ]] levels in both control and Dbh -/- mice, demonstrating that NE is not required for the regulation of NET by antidepressant drugs.", "label": "INDIRECT-DOWNREGULATOR", "metadata": []}
{"text": "Probes were perfused with artificial cerebrospinal fluid containing nicotine, the specific << alpha(4)beta(2*) nAChR >> agonist [[ metanicotine ]], or nicotine plus nAChR antagonists and norepinephrine measured in the microdialysates.", "label": "AGONIST", "metadata": []}
{"text": "We changed the residues to alanine using site-directed mutagenesis technique, expressed the mutants in a baculovirus/Sf9 cell system, and analyzed the kinetic characteristics of inhibition of the mutant enzymes by << milrinone >> and cilostazol, specific inhibitors of [[ PDE3 ]].", "label": "INHIBITOR", "metadata": []}
{"text": "It is caused by a deficiency of << propionyl-CoA carboxylase >> (PCC, EC 6.4.1.3), a biotin-dependent enzyme that catalyzes the carboxylation of propionyl-CoA to [[ D-methylmalonyl-CoA ]].", "label": "SUBSTRATE", "metadata": []}
{"text": "The effects of histamine H1-receptor antagonists, << promethazine >> and homochlorcyclizine, both of which are inhibitors of [[ CYP2D6 ]], on the steady-state plasma concentrations (Css) of haloperidol and reduced haloperidol were studied in 23 schizophrenic inpatients receiving haloperidol, 12 to 36 mg/d, for 2 to 29 weeks.", "label": "INHIBITOR", "metadata": []}
{"text": "<< alpha(1A)-Adrenoceptor >> selective antagonists, [[ 2-([2,6-dimethoxyphenoxyethyl]aminomethyl)-1,4-benzodioxane ]] (WB-4101; 0.1-1 mg/kg) and 5-methylurapidil (0.1-1 mg/kg), the alpha(1B)-adrenoceptor selective antagonist, 4-amino-2-[4-[1-(benzyloxycarbonyl)-2(S)- [[(1,1-dimethylethyl)amino]carbonyl]-piperazinyl]-6,7-dimethoxyquinazoline (L-765314; 0.3-1 mg/kg), as well as the alpha(1D)-adrenoceptor selective antagonist, 8-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-8-azaspiro[4.5]decane-7,9-dione (BMY-7378; 1 mg/kg), were used to delineate the adrenoceptor subtypes involved.", "label": "ANTAGONIST", "metadata": []}
{"text": "<< alpha(1A)-Adrenoceptor >> selective antagonists, 2-([2,6-dimethoxyphenoxyethyl]aminomethyl)-1,4-benzodioxane ([[ WB-4101 ]]; 0.1-1 mg/kg) and 5-methylurapidil (0.1-1 mg/kg), the alpha(1B)-adrenoceptor selective antagonist, 4-amino-2-[4-[1-(benzyloxycarbonyl)-2(S)- [[(1,1-dimethylethyl)amino]carbonyl]-piperazinyl]-6,7-dimethoxyquinazoline (L-765314; 0.3-1 mg/kg), as well as the alpha(1D)-adrenoceptor selective antagonist, 8-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-8-azaspiro[4.5]decane-7,9-dione (BMY-7378; 1 mg/kg), were used to delineate the adrenoceptor subtypes involved.", "label": "ANTAGONIST", "metadata": []}
{"text": "alpha(1A)-Adrenoceptor selective antagonists, 2-([2,6-dimethoxyphenoxyethyl]aminomethyl)-1,4-benzodioxane (WB-4101; 0.1-1 mg/kg) and 5-methylurapidil (0.1-1 mg/kg), the alpha(1B)-adrenoceptor selective antagonist, 4-amino-2-[4-[1-(benzyloxycarbonyl)-2(S)- [[(1,1-dimethylethyl)amino]carbonyl]-piperazinyl]-6,7-dimethoxyquinazoline (L-765314; 0.3-1 mg/kg), as well as the << alpha(1D)-adrenoceptor >> selective antagonist, [[ 8-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-8-azaspiro[4.5]decane-7,9-dione ]] (BMY-7378; 1 mg/kg), were used to delineate the adrenoceptor subtypes involved.", "label": "ANTAGONIST", "metadata": []}
{"text": "A cDNA encoding the complete amino acid sequence of aminoacylase 1 (<< N-acylamino acid aminohydrolase >>, ACY-1) [EC 3.5.1.14], a dimeric metalloprotein having two Zn2+ in the molecule, which catalyzes the deacylation of [[ N-acylated L-amino acids ]] except L-aspartic acid, has been isolated from porcine kidney lambda gt10 cDNA library and sequenced.", "label": "SUBSTRATE", "metadata": []}
{"text": "Patients stable on warfarin therapy and concurrently taking a cyclooxygenase-2 (<< COX-2 >>) inhibitor comparator (traditional nonsteroidal antiinflammatory medications, [[ salsalate ]], or acetaminophen) randomly received celecoxib 200 mg/day or rofecoxib 25 mg/day for three weeks.", "label": "INHIBITOR", "metadata": []}
{"text": "Patients stable on warfarin therapy and concurrently taking a << cyclooxygenase-2 >> (COX-2) inhibitor comparator (traditional nonsteroidal antiinflammatory medications, salsalate, or acetaminophen) randomly received [[ celecoxib ]] 200 mg/day or rofecoxib 25 mg/day for three weeks.", "label": "INHIBITOR", "metadata": []}
{"text": "We sought to assess the effects of the << angiotensin type 1 (AT1) receptor >> blocker [[ eprosartan ]] on HRV and BRG.", "label": "INHIBITOR", "metadata": []}
{"text": "The antinociceptive activity of the << alpha 2-adrenoceptor >> agonist [[ clonidine ]] was also increased in mice treated with alpha N-acetyl beta-endorphin-(1-31).", "label": "AGONIST", "metadata": []}
{"text": "After the combined pituitary stimulation test (100 micrograms human CRH, 100 micrograms GnRH, 100 micrograms GH-releasing hormone, and 200 micrograms TRH), the << ACTH >> peak (maximum increase at 30 min) was significantly blunted by [[ loperamide ]] from 9 +/- 1 to 4 +/- 1 pmol/L (P less than 0.001) and the area under the curve of ACTH from 0-120 min was reduced from 35 +/- 5 to 23 +/- 4 pmol/L.2 h (P less than 0.05).", "label": "DOWNREGULATOR", "metadata": []}
{"text": "Ribonucleotide reductase (<< RR >>) is responsible for the de novo conversion of the ribonucleoside diphosphates to [[ deoxyribonucleoside diphosphates ]], which are essential for DNA synthesis and repair.", "label": "PRODUCT-OF", "metadata": []}
{"text": "Ribonucleotide reductase (<< RR >>) is responsible for the de novo conversion of the [[ ribonucleoside diphosphates ]] to deoxyribonucleoside diphosphates, which are essential for DNA synthesis and repair.", "label": "SUBSTRATE", "metadata": []}
{"text": "CONCLUSION: << Nandrolone phenylpropionate >> up-regulated the density of [[ AR ]] in liver tissue, whereas it had no significant effects on the density of AR in testis and ovary tissues.", "label": "INDIRECT-UPREGULATOR", "metadata": []}
{"text": "The pretreatment with << salbutamol >> induced a 59% down-regulation of left ventricular [[ beta(2)-adrenoceptors ]] compared to control.", "label": "DOWNREGULATOR", "metadata": []}
{"text": "<< TRPM8 >> (CMR1) is a Ca(2+)-permeable channel, which can be activated by low temperatures, menthol, eucalyptol and [[ icilin ]].", "label": "ACTIVATOR", "metadata": []}
{"text": "Known << VR1 >> antagonists (BCTC, thio-BCTC and [[ capsazepine ]]) were also able to block the response of TRPM8 to menthol (IC(50): 0.8+/-1.0, 3.5+/-1.1 and 18+/-1.1 microM, respectively).", "label": "ANTAGONIST", "metadata": []}
{"text": "Although highly homologous to other class III RTKs, Flt3 is resistant to the phenylaminopyrimidine STI571 (Gleevec, << Imatinib >>), a potent inhibitor of other [[ RTKs ]] in the family, such as the PDGFbeta-receptor or c-Kit.", "label": "INHIBITOR", "metadata": []}
{"text": "Although highly homologous to other class III RTKs, Flt3 is resistant to the phenylaminopyrimidine STI571 (Gleevec, << Imatinib >>), a potent inhibitor of other RTKs in the family, such as the PDGFbeta-receptor or [[ c-Kit ]].", "label": "INHIBITOR", "metadata": []}
{"text": "Novel mechanism of action for << hydralazine >>: induction of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and angiogenesis by inhibition of [[ prolyl hydroxylases ]].", "label": "INHIBITOR", "metadata": []}
{"text": "<< Hydralazine >> induced rapid and transient expression of HIF-1alpha and downstream targets of HIF (endothelin-1, [[ adrenomedullin ]], haem oxygenase 1, and vascular endothelial growth factor [VEGF]) in endothelial and smooth muscle cells and induced endothelial cell-specific proliferation.", "label": "INDIRECT-UPREGULATOR", "metadata": []}
{"text": "CONCLUSIONS AND CLINICAL RELEVANCE: Canine COX-2 was selectively inhibited by etodolac, nimesulide, and NS398; << tolfenamic acid >> and carprofen also appeared to be preferential [[ COX-2 ]] inhibitors in dogs.", "label": "INHIBITOR", "metadata": []}
{"text": "In contrast, inhibition of << rat liver squalene epoxidase >> only occurs at higher drug concentrations (Ki = 77 microM), and is competitive with [[ squalene ]].", "label": "INHIBITOR", "metadata": []}
{"text": "RESULTS: << Imatinib >>, despite equivocal efficacy as monotherapy, reduced pericyte coverage of tumor vessels and enhanced efficacy in combination with metronomic chemotherapy or [[ VEGFR ]] inhibition.", "label": "INHIBITOR", "metadata": []}
{"text": "Pre-irradiation administration of RP-1 enhanced levels of << GSH >> induced increase in [[ complex I ]] (upto 16 h), complex I/III (4 h) complex II/III activity (upto 24 h; p < 0.01) and inhibited the radiation-induced decrease in MMP significantly (24 h; p < 0.01).", "label": "ACTIVATOR", "metadata": []}
{"text": "Cystathionine-gamma-lyase (CSE) and cystathionine-beta-synthase (<< CBS >>) utilize L-cysteine as substrate to form [[ H2S ]].", "label": "PRODUCT-OF", "metadata": []}
{"text": "Of these two enzymes, << cystathionine-gamma-lyase >> (CSE) is believed to be the key enzyme that forms [[ H2S ]] in the cardiovascular system.", "label": "PRODUCT-OF", "metadata": []}
{"text": "Of these two enzymes, cystathionine-gamma-lyase (<< CSE >>) is believed to be the key enzyme that forms [[ H2S ]] in the cardiovascular system.", "label": "PRODUCT-OF", "metadata": []}
{"text": "Also, prophylactic, as well as therapeutic, treatment with the CSE inhibitor, DL-propargylglycine (PAG), significantly reduced the severity of caerulein-induced pancreatitis and associated lung injury, as determined by 1) hyperamylasemia [plasma amylase (U/L) (control, 1204+/-59); prophylactic treatment: placebo, 10635+/-305; PAG, 7904+/-495; therapeutic treatment: placebo, 10427+/-470; PAG, 7811+/-428; P<0.05 PAG c.f. placebo; n=24 animals in each group]; 2) neutrophil sequestration in the pancreas [pancreatic myeloperoxidase oxidase (<< MPO >>) activity (fold increase over control) (prophylactic treatment: placebo, 5.78+/-0.63; [[ PAG ]], 2.97+/-0.39; therapeutic treatment: placebo, 5.48+/-0.52; PAG, 3.03+/-0.47; P<0.05 PAG c.f. placebo; n=24 animals in each group)]; 3) pancreatic acinar cell injury/necrosis; 4) lung MPO activity (fold increase over control) [prophylactic treatment: placebo, 1.99+/-0.16; PAG, 1.34+/-0.14; therapeutic treatment: placebo, 2.03+/-0.12; PAG, 1.41+/-0.97; P<0.05 PAG c.f. placebo; n=24 animals in each group]; and 5) histological evidence of lung injury.", "label": "ACTIVATOR", "metadata": []}
{"text": "NPC1L1 could recently be identified as a major << sterol transporter >> for the intestinal uptake of [[ cholesterol ]] as well as plant sterols.", "label": "SUBSTRATE", "metadata": []}
{"text": "<< NPC1L1 >> could recently be identified as a major sterol transporter for the intestinal uptake of cholesterol as well as plant [[ sterols ]].", "label": "SUBSTRATE", "metadata": []}
{"text": "A number of selective << 5-HT3 >> antagonists have been developed including [[ ondansetron ]], granisetron, tropisetron renzapride and zacopride.", "label": "ANTAGONIST", "metadata": []}
{"text": "While the substituted benzamide prokinetics (for example, << metoclopramide >>, cisapride) also block 5-HT3 receptors in high concentrations, their prokinetic action is believed to be on the basis of their agonist effects on the putative [[ 5-HT4 ]] receptor.", "label": "AGONIST", "metadata": []}
{"text": "When the growth condition was shifted from aerobic to anaerobic, the increased level of succinate in SDH1 disruptants was no longer observed, whereas the decreased level of << succinate >> in the [[ KGD1 ]] diruptant was still observed.", "label": "PRODUCT-OF", "metadata": []}
{"text": "A double mutant of the two << fumarate reductase >> isozyme genes (OSM1 and FRDS) showed a [[ succinate ]] productivity of 50% as compared to the parent when cells were incubated in glucose-buffered solution.", "label": "PRODUCT-OF", "metadata": []}
{"text": "However, plasma << high-density lipoprotein >>-cholesterol (HDL-C) and HDL-C/total-C ratio levels and plasma paraoxonase activity were only significantly higher in [[ vitamin E ]] group after 8 weeks.", "label": "INDIRECT-UPREGULATOR", "metadata": []}
{"text": "Hepatic << ACAT >> activity was significantly lower in both [[ vitamin E ]] and probucol groups than in HC-control group, while HMG-CoA reductase activity was the highest only in the probucol group.", "label": "INHIBITOR", "metadata": []}
{"text": "Hepatic << ACAT >> activity was significantly lower in both vitamin E and [[ probucol ]] groups than in HC-control group, while HMG-CoA reductase activity was the highest only in the probucol group.", "label": "INHIBITOR", "metadata": []}
{"text": "<< Maraviroc >> inhibited binding of [125I]-MIP-1beta to CCR5 from macaque and human with similar potency (IC50 = 17.50 +/- 1.24 nM and 7.18 +/- 0.93 nM, respectively) and antagonised MIP-1beta induced intracellular calcium release mediated through [[ CCR5 ]] from macaque and human with similar potency (IC50 = 17.50 +/- 3.30 nM and 12.07 +/- 1.89, respectively).", "label": "ANTAGONIST", "metadata": []}
{"text": "Valproic acid selectively inhibits conversion of arachidonic acid to << arachidonoyl-CoA >> by [[ brain microsomal long-chain fatty acyl-CoA synthetases ]]: relevance to bipolar disorder.", "label": "PRODUCT-OF", "metadata": []}
{"text": "CONCLUSIONS: This study shows that << valproic acid >> acts as a non-competitive inhibitor of [[ brain microsomal Acsl ]], and that inhibition is substrate-selective.", "label": "INHIBITOR", "metadata": []}
{"text": "Involvement of << COX-1 >> and up-regulated prostaglandin E synthases in phosphatidylserine liposome-induced [[ prostaglandin E2 ]] production by microglia.", "label": "PRODUCT-OF", "metadata": []}
{"text": "These observations strongly suggest that the up-regulation of terminal PGESs that are preferentially coupled with COX-1, especially << mPGES-2 >>, plays the pivotal role in PS liposome-induced [[ PGE2 ]] production by microglia.", "label": "PRODUCT-OF", "metadata": []}
{"text": "Significant advances in the treatment of clear-cell RCC have been derived from agents that target these pathways, including the multiple-kinase inhibitors (MKIs) << sorafenib >>, sunitinib, and AG013736, which target multiple [[ VEGFRs ]] as well as PDGFR-beta.", "label": "INHIBITOR", "metadata": []}
{"text": "Significant advances in the treatment of clear-cell RCC have been derived from agents that target these pathways, including the multiple-<< kinase >> inhibitors (MKIs) sorafenib, sunitinib, and [[ AG013736 ]], which target multiple VEGFRs as well as PDGFR-beta.", "label": "INHIBITOR", "metadata": []}
{"text": "<< Sorafenib >> has the added advantage of inhibiting multiple different Raf isoforms, which enables it to target TGF-alpha/EGFR signaling and may also enhance its inhibition of VEGFR and [[ PDGFR-beta ]].", "label": "INHIBITOR", "metadata": []}
{"text": "Similar to menthol, both camphor and << cinnamaldehyde >> (initially reported to be specific activators of [[ TRPV3 ]] and TRPA1, respectively) also modulate other thermoTRPs.", "label": "ACTIVATOR", "metadata": []}
{"text": "These currents were produced by glutamate-aspartate transporters (GLAST) (<< excitatory amino acid transporter 1 >>) because they were weakly inhibited by [[ dihydrokainate ]], an antagonist of glutamate transporter-1 (excitatory amino acid transporter 2) and were absent from IPCs in GLAST-/- cochleas.", "label": "INHIBITOR", "metadata": []}
{"text": "Proline oxidase (<< POX >>), a mitochondrial inner-membrane protein, catalyzes the rate-limiting oxidation of [[ proline ]] to pyrroline- 5-carboxylate (P5C).", "label": "SUBSTRATE", "metadata": []}
{"text": "The apoptotic effect is specific for L-proline, detectable at 0.2 mM, maximal at 1 mM, and occurs during 48-72 h following the addition of << L-proline >> to cells with maximally induced [[ POX ]].", "label": "SUBSTRATE", "metadata": []}
{"text": "K(m) values of the mutants for << cGMP >> were similar to that of full-length [[ PDE5 ]].", "label": "SUBSTRATE", "metadata": []}
{"text": "<< VGLUT1 >> is localized in transcytotic vesicles and accumulates [[ L-glutamate ]].", "label": "SUBSTRATE", "metadata": []}
{"text": "CONCLUSION: Intake of high SFAs and MUFAs appears to increase expression of PBMC D6D and D5D genes, whilst high << EFAs >> intake appears to decrease expression of PBMC D6D and [[ D5D ]] genes.", "label": "INDIRECT-DOWNREGULATOR", "metadata": []}
{"text": "KIEs were measured on the arsenolysis of << 5'-methylthioadenosine >> (MTA) catalyzed by [[ MTAP ]] and were corrected for the forward commitment to catalysis.", "label": "SUBSTRATE", "metadata": []}
{"text": "In conclusion, our results indicate that << Cd >> increases BC cell proliferation in vitro by stimulating Akt, ERK1/2 and [[ PDGFRalpha ]] kinases activity likely by activating c-fos, c-jun and PDGFA by an ERalpha-dependent mechanism.", "label": "ACTIVATOR", "metadata": []}
{"text": "Some clinically used compounds, such as << acetazolamide >>, methazolamide, ethoxzolamide, dichlorophenamide, dorzolamide, brinzolamide, topiramate, sulpiride, and indisulam, or the orphan drug benzolamide, showed effective [[ hCA VI ]] inhibitory activity, with inhibition constants of 0.8-79 nM.", "label": "INHIBITOR", "metadata": []}
{"text": "Some of the compounds investigated in this study might be used as additives in toothpastes for reducing the acidification produced by the relevant CO2 hydrase activity of enamel << CA VI >>, which leads to the formation of protons and [[ bicarbonate ]] and may have a role in cariogenesis.", "label": "SUBSTRATE_PRODUCT-OF", "metadata": []}
{"text": "Here, we report that the antifibrotic drug << 5-methyl-1-phenyl-2-(1H)-pyridone >> (pirfenidone, PFD) elicits growth-inhibitory effects and reduces [[ TGF-beta2 ]] protein levels in human glioma cell lines.", "label": "INDIRECT-DOWNREGULATOR", "metadata": []}
{"text": "Mechanism of the irreversible inactivation of << mouse ornithine decarboxylase >> by [[ alpha-difluoromethylornithine ]].", "label": "INHIBITOR", "metadata": []}
{"text": "Na+-Dependent transmembrane transport of small neutral << amino acids >>, such as glutamine and alanine, is mediated, among others, by the neutral amino acid transporters of the solute carrier 1 [SLC1, [[ alanine serine cysteine transporter 1 ]] (ASCT1), and ASCT2] and SLC38 families [sodium-coupled neutral amino acid transporter 1 (SNAT1), SNAT2, and SNAT4].", "label": "SUBSTRATE", "metadata": []}
{"text": "Na+-Dependent transmembrane transport of small neutral amino acids, such as glutamine and << alanine >>, is mediated, among others, by the [[ neutral amino acid transporters ]] of the solute carrier 1 [SLC1, alanine serine cysteine transporter 1 (ASCT1), and ASCT2] and SLC38 families [sodium-coupled neutral amino acid transporter 1 (SNAT1), SNAT2, and SNAT4].", "label": "SUBSTRATE", "metadata": []}
{"text": "Here, we describe a new photolabile alanine derivative based on protection of alanine with the 4-methoxy-7-nitroindolinyl (<< MNI >>) caging group, which we use for pre-steady-state kinetic analysis of alanine transport by ASCT2, [[ SNAT1 ]], and SNAT2.", "label": "SUBSTRATE", "metadata": []}
{"text": "At least 4 h of estrogen pre-treatment was required to elicit protection, an effect that was blocked by the << ER >> antagonist, [[ ICI 182,780 ]].", "label": "ANTAGONIST", "metadata": []}
{"text": "Repeated << cocaine >> resulted in [[ CREB ]] phosphorylation in all analyzed subregions of the NAc excluding the most ventrolateral region of the shell 2 weeks after cessation of repeated cocaine, but rats challenged after 2 drug-free days yielded a more localized activation of CREB in the 3 most dorsomedial zones of the shell.", "label": "ACTIVATOR", "metadata": []}
{"text": "Finally, we demonstrate that << T. thermophilus PRODH >> reacts with [[ O(2) ]] producing superoxide.", "label": "SUBSTRATE", "metadata": []}
{"text": "This is significant because << superoxide >> production underlies the role of [[ human PRODH ]] in p53-mediated apoptosis, implying commonalities between eukaryotic and bacterial monofunctional PRODHs.", "label": "PRODUCT-OF", "metadata": []}
{"text": "Consequently, << PDE4 >> inhibitors including [[ cilomilast ]] and AWD 12-281 have been tested in several models of allergic and irritant skin inflammation.", "label": "INHIBITOR", "metadata": []}
{"text": "Because of their low asparagine synthetase (<< ASNS >>) expression and [[ asparagine ]] biosynthesis, acute lymphoblastic leukemia (ALL) cells are exquisitely sensitive to asparagine depletion.", "label": "PRODUCT-OF", "metadata": []}
{"text": "MK-801 (<< (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine maleate >>), a noncompetitive [[ NMDA receptor ]] antagonist, partially prevented the decrease in cell viability and the energy impairment.", "label": "ANTAGONIST", "metadata": []}
{"text": "The use of << Delta 6 desaturase >> (D6D) twice in the conversion of alpha-linolenic acid (ALA; 18:3n-3) to [[ docosahexaenoic acid ]] (DHA; 22:6n-3) suggests that this enzyme may play a key regulatory role in the synthesis and accumulation of DHA from ALA.", "label": "PRODUCT-OF", "metadata": []}
{"text": "The use of Delta 6 desaturase (<< D6D >>) twice in the conversion of [[ alpha-linolenic acid ]] (ALA; 18:3n-3) to docosahexaenoic acid (DHA; 22:6n-3) suggests that this enzyme may play a key regulatory role in the synthesis and accumulation of DHA from ALA.", "label": "SUBSTRATE", "metadata": []}
{"text": "The parallel pattern of accumulation of 24:6n-3 and DHA in response to increasing concentrations of ALA suggests that the competition between 24:5n-3 and << ALA >> for [[ D6D ]] may contribute to the limited accumulation of DHA in cell membranes.", "label": "SUBSTRATE", "metadata": []}
{"text": "(-)-Stepholidine (<< SPD >>), an active ingredient of the Chinese herb Stephania, is the first compound found to have dual function as a dopamine receptor D1 agonist and [[ D2 ]] antagonist.", "label": "ANTAGONIST", "metadata": []}
{"text": "<< Estrogen >> protects against mitochondrial dysfunction caused by excitotoxicity by maintaining cellular redox status through higher constitutive expression of [[ glutaredoxin ]] in the CNS.", "label": "INDIRECT-UPREGULATOR", "metadata": []}
{"text": "Interestingly, the VIAAT ortholog from Caenorhabditis elegans (UNC-47), a species lacking glycine transmission, also supports << glycine >> exocytosis in the presence of [[ GlyT2 ]], and a point mutation of UNC-47 that abolishes GABA transmission in the worm confers glycine specificity.", "label": "SUBSTRATE", "metadata": []}
{"text": "<< Na+ >>/Cl- dipole couples agonist binding to [[ kainate receptor ]] activation.", "label": "ACTIVATOR", "metadata": []}
{"text": "Phenserine. << Phenserine >>, a derivative of physostigmine, was first described as an inhibitor of acetylcholinesterase ([[ AChE ]]) and was shown to improve cognition in various experimental paradigms in rodents and dogs.", "label": "INHIBITOR", "metadata": []}
{"text": "Phenserine is also unique because of differing actions of its enantiomers: (-)-phenserine is the active enantiomer for inhibition of AChE, whereas << (+)-phenserine >> ('posiphen') has weak activity as an [[ AChE ]] inhibitor and can be dosed much higher.", "label": "INHIBITOR", "metadata": []}
{"text": "BACKGROUND AND PURPOSE: AMP-activated protein kinase (<< AMPK >>) is activated by [[ metformin ]], phenformin, and the AMP mimetic, 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAR).", "label": "ACTIVATOR", "metadata": []}
{"text": "BACKGROUND AND PURPOSE: AMP-activated protein kinase (<< AMPK >>) is activated by metformin, phenformin, and the AMP mimetic, [[ 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside ]] (AICAR).", "label": "ACTIVATOR", "metadata": []}
{"text": "KEY RESULTS: Phenformin, << AICAR >> and metformin increased [[ AMPK (alpha1) ]] activity and decreased I(amiloride).", "label": "ACTIVATOR", "metadata": []}
{"text": "LTC4 synthase (LTC4S), the pivotal enzyme for the biosynthesis of LTC4 (ref. 10), is an 18-kDa integral nuclear membrane protein that belongs to a superfamily of membrane-associated proteins in eicosanoid and << glutathione >> metabolism that includes 5-lipoxygenase-activating protein, microsomal glutathione S-transferases (MGSTs), and [[ microsomal prostaglandin E synthase 1 ]] (ref. 13).", "label": "SUBSTRATE", "metadata": []}
{"text": "Phenelzine (<< PLZ >>), a nonselective irreversible inhibitor of monoamine oxidase ([[ MAO ]]), also inhibits GABA-transaminase (GABA-T), markedly increasing brain GABA levels.", "label": "INHIBITOR", "metadata": []}
{"text": "Caution is necessary only when it is coadministered with drugs metabolised by << CYP2D6 >>, such as [[ metoprolol ]], or administered to the elderly or patients with severe hepatic or renal impairment.", "label": "SUBSTRATE", "metadata": []}
{"text": "The principal aim of the study was to find << amiodarone >> analogues that retained [[ human ether-a-go-go-related protein (hERG) channel ]] inhibition but with reduced cytotoxicity.", "label": "INHIBITOR", "metadata": []}
{"text": "While a number of orally active non-peptide V(2) antagonists (Vaptans); notably, Tolvaptan, Lixivaptan and Satavaptan, are currently in Phase III clinical trials; to date, only the mixed V(2)/<< V(1a) >>, antagonist Conivaptan ([[ Vaprisol ]]), has been approved by the US FDA for clinical use (by i.v. administration), for the treatment of euvolemic and hypervolemic hyponatremia in hospitalized patients.", "label": "ANTAGONIST", "metadata": []}
{"text": "Absorbable drugs (fibric acids, << nicotinic acid >>, probucol, HMG-CoA reductase inhibitors) reduce [[ plasma very-low-density lipoproteins ]] (VLDL) and/or low-density lipoproteins (LDL) by a variety of mechanisms.", "label": "INDIRECT-DOWNREGULATOR", "metadata": []}
{"text": "Absorbable drugs (fibric acids, << nicotinic acid >>, probucol, HMG-CoA reductase inhibitors) reduce plasma very-low-density lipoproteins (VLDL) and/or low-density lipoproteins ([[ LDL ]]) by a variety of mechanisms.", "label": "INDIRECT-DOWNREGULATOR", "metadata": []}
{"text": "Absorbable drugs (fibric acids, nicotinic acid, << probucol >>, HMG-CoA reductase inhibitors) reduce plasma very-low-density lipoproteins (VLDL) and/or low-density lipoproteins ([[ LDL ]]) by a variety of mechanisms.", "label": "INDIRECT-DOWNREGULATOR", "metadata": []}
{"text": "<< Fibric acids >>, in particular, act by stimulating the catabolism of [[ VLDL ]] and also, as a consequence, improving LDL delipidation, thus favoring receptor uptake.", "label": "INDIRECT-DOWNREGULATOR", "metadata": []}
{"text": "BACKGROUND: << Lapatinib >>, the first dual inhibitor of epidermal growth factor receptor (EGFR) and [[ human epidermal growth factor receptor 2 ]] (HER2) tyrosine kinases, was approved by the US Food and Drug Administration (FDA) in 2007.", "label": "INHIBITOR", "metadata": []}
{"text": "<< Quinpirole >> and 7-OH-DPAT also increased the phosphorylation of [[ extracellular signal-regulated kinase ]] (ERK) within minutes, an effect blocked by pretreatment with SB-277011-A.", "label": "ACTIVATOR", "metadata": []}
{"text": "Quinpirole and << 7-OH-DPAT >> also increased the phosphorylation of [[ extracellular signal-regulated kinase ]] (ERK) within minutes, an effect blocked by pretreatment with SB-277011-A.", "label": "ACTIVATOR", "metadata": []}
{"text": "We found compounds that inhibited << Panx1 >> currents with a rank order of potency: [[ carbenoxolone ]] > disodium 4,4'-diisothiocyanatostilbene-2,2'-disulfonate (DIDS) approximately disodium 4-acetamido-4'-isothiocyanato-stilben-2,2'-disulfonate approximately 5-nitro-2-(3-phenylpropylamino)benzoic acid > indanyloxyacetic acid 94 >> probenecid >> flufenamic acid = niflumic acid.", "label": "INHIBITOR", "metadata": []}
{"text": "MMP-2 and << MMP-9 >> expressions and activities in right ventricles increased significantly in [[ monocrotaline ]]-injected rats and captopril inhibited them.", "label": "INDIRECT-UPREGULATOR", "metadata": []}
{"text": "MMP-2 and << MMP-9 >> expressions and activities in right ventricles increased significantly in monocrotaline-injected rats and [[ captopril ]] inhibited them.", "label": "INDIRECT-DOWNREGULATOR", "metadata": []}
{"text": "These findings indicate that captopril attenuates the development of << monocrotaline >>-induced right ventricular hypertrophy in association with inhibition of [[ MMP-2 ]] and MMP-9 in rats.", "label": "ACTIVATOR", "metadata": []}
{"text": "<< Thiazide >> and high ceiling diuretics were recently shown to inhibit all mammalian isoforms of carbonic anhydrase (CA, [[ EC 4.2.1.1 ]]) with a very different profile as compared to classical inhibitors, such as acetazolamide, methazolamide, and ethoxzolamide.", "label": "INHIBITOR", "metadata": []}
{"text": "Thiazide and high ceiling diuretics were recently shown to inhibit all mammalian isoforms of carbonic anhydrase (<< CA >>, EC 4.2.1.1) with a very different profile as compared to classical inhibitors, such as [[ acetazolamide ]], methazolamide, and ethoxzolamide.", "label": "INHIBITOR", "metadata": []}
{"text": "Thiazide and high ceiling diuretics were recently shown to inhibit all mammalian isoforms of carbonic anhydrase (CA, << EC 4.2.1.1 >>) with a very different profile as compared to classical inhibitors, such as [[ acetazolamide ]], methazolamide, and ethoxzolamide.", "label": "INHIBITOR", "metadata": []}
{"text": "Thiazide and high ceiling diuretics were recently shown to inhibit all mammalian isoforms of carbonic anhydrase (CA, << EC 4.2.1.1 >>) with a very different profile as compared to classical inhibitors, such as acetazolamide, methazolamide, and [[ ethoxzolamide ]].", "label": "INHIBITOR", "metadata": []}
{"text": "Thiazide and high ceiling diuretics were recently shown to inhibit all mammalian isoforms of << carbonic anhydrase >> (CA, EC 4.2.1.1) with a very different profile as compared to classical inhibitors, such as acetazolamide, methazolamide, and [[ ethoxzolamide ]].", "label": "INHIBITOR", "metadata": []}
{"text": "Some of these structurally related compounds have a very different behavior against the widespread isozyme CA II, with << chlorthalidone >>, trichloromethiazide, and furosemide being efficient inhibitors against [[ CA II ]] (K(I)s of 65-138 nM), whereas indapamide is a much weaker one (K(I) of 2520 nM).", "label": "INHIBITOR", "metadata": []}
{"text": "Chronic treatment with << sergliflozin etabonate >> reduced the levels of [[ glycated hemoglobin ]] and fasting plasma glucose, and improved the glycemic response after glucose loading in Zucker fatty rats.", "label": "INDIRECT-DOWNREGULATOR", "metadata": []}
{"text": "The inhibitory effect of fenoldopam on insulin-mediated VSMC proliferation was receptor specific, because its effect could be blocked by << SCH23390 >>, a [[ D1-like receptor ]] antagonist.", "label": "ANTAGONIST", "metadata": []}
{"text": "The mechanism of << OP >> poisoning involves inhibition of [[ acetylcholinesterase ]] (AChE) leading to inactivation of the enzyme which has an important role in neurotransmission.", "label": "INHIBITOR", "metadata": []}
{"text": "The mechanism of << OP >> poisoning involves inhibition of acetylcholinesterase ([[ AChE ]]) leading to inactivation of the enzyme which has an important role in neurotransmission.", "label": "INHIBITOR", "metadata": []}
{"text": "Presently, a combination of an antimuscarinic agent, e.g. atropine, << AChE >> reactivator such as one of the recommended pyridinium oximes (pralidoxime, trimedoxime, [[ obidoxime ]] and HI-6) and diazepam are used for the treatment of OP poisoning in humans.", "label": "ACTIVATOR", "metadata": []}
{"text": "Presently, a combination of an antimuscarinic agent, e.g. atropine, << AChE >> reactivator such as one of the recommended pyridinium oximes (pralidoxime, trimedoxime, obidoxime and HI-6) and [[ diazepam ]] are used for the treatment of OP poisoning in humans.", "label": "ACTIVATOR", "metadata": []}
{"text": "Luteinizing hormone-releasing hormone (<< LHRH >>) agonists, such as buserelin, [[ goserelin ]], leuprorelin and triptorelin, stimulate the pituitary's gonadotrophin-releasing hormone (GnRH) receptor, ultimately leading to its de-sensitization and subsequent reduction of LH and testosterone levels.", "label": "AGONIST", "metadata": []}
{"text": "It is proposed that two molecules of << estramustine phosphate >> interact with each of the three tubulin-binding sites of MAP2 and inhibit the MAP2:[[ tubulin ]] interaction by neutralising two highly conserved basic residues.", "label": "INHIBITOR", "metadata": []}
{"text": "PURPOSE: XL184 (<< cabozantinib >>) is a potent inhibitor of MET, vascular endothelial growth factor receptor 2 (VEGFR2), and [[ RET ]], with robust antiangiogenic, antitumor, and anti-invasive effects in preclinical models.", "label": "INHIBITOR", "metadata": []}
{"text": "PURPOSE: XL184 (<< cabozantinib >>) is a potent inhibitor of MET, [[ vascular endothelial growth factor receptor 2 ]] (VEGFR2), and RET, with robust antiangiogenic, antitumor, and anti-invasive effects in preclinical models.", "label": "INHIBITOR", "metadata": []}
{"text": "PURPOSE: << XL184 >> (cabozantinib) is a potent inhibitor of [[ MET ]], vascular endothelial growth factor receptor 2 (VEGFR2), and RET, with robust antiangiogenic, antitumor, and anti-invasive effects in preclinical models.", "label": "INHIBITOR", "metadata": []}
{"text": "<< Human placental 3 beta-hydroxysteroid dehydrogenase/5----4-ene isomerase >> (3 beta-HSD) purified from human placenta transforms C-21 (pregnenolone and 17 alpha-hydroxy pregnenolone) as well as C-19 (dehydroepiandrosterone and [[ androst-5-ene-3 beta, 17 beta-diol ]]) steroids into the corresponding 3-keto-4-ene-steroids and is thus involved in the biosynthesis of all classes of hormonal steroids.", "label": "SUBSTRATE", "metadata": []}
{"text": "Cyproterone acetate, a << progestin >> used in the treatment of hirsutism, acne and prostate cancer as well as norgestrel and norethindrone that are widely used as oral contraceptives also inhibit [[ 3 beta-HSD ]] activity at Ki values of 1.5, 1.7 and 2.5 microM, respectively.", "label": "INHIBITOR", "metadata": []}
{"text": "These findings suggest that oral consumption of << nicotine >> enhances the efficacy of [[ nicotinic acetylcholine receptors ]].", "label": "INDIRECT-UPREGULATOR", "metadata": []}
{"text": "We examined in cats the 1) ulcerogenic effects of selective COX-1 (SC-560, ketorolac) and << COX-2 >> (celecoxib, [[ meloxicam ]]) inhibitors on the gastrointestinal mucosa, 2) effect of feeding and cimetidine on the expression of COX isoforms and prostaglandin E(2) (PGE(2)) level in the duodenum, and 3) localization of COX isoforms in the duodenum.", "label": "INHIBITOR", "metadata": []}
{"text": "Reversal of inhibition by << D2 >> agonist [[ quinpirole ]] was produced by serotonin (50 µM) and by neurotensin (5-10 nM).", "label": "AGONIST", "metadata": []}
{"text": "Serotonin-induced or neurotensin-induced reversal was blocked by β-ARK1 inhibitor, dynasore, or << cPKC >> antagonist 5,6,7,13-tetrahydro-13-methyl-5-oxo-12H-indolo[2,3-a]pyrrolo[3,4c]carbazole-12-propanenitrile ([[ Gö6976 ]]).", "label": "ANTAGONIST", "metadata": []}
{"text": "<< RSV >> targets and activates the NAD(+)-dependent protein deacetylase SIRT1; in turn, SIRT1 induces an intracellular antioxidative mechanism by inducing mitochondrial superoxide dismutase ([[ SOD2 ]]).", "label": "INDIRECT-UPREGULATOR", "metadata": []}
{"text": "However, << 4'G-RSV >>, but not 3G-RSV, induced SIRT1-dependent histone H3 deacetylation and [[ SOD2 ]] expression in mouse C2C12 skeletal myoblasts; as with RSV, SIRT1 knockdown blunted these effects.", "label": "INDIRECT-UPREGULATOR", "metadata": []}
{"text": "Efficacy of the << GluK1 >>/AMPA receptor antagonist [[ LY293558 ]] against seizures and neuropathology in a soman-exposure model without pretreatment and its pharmacokinetics after intramuscular administration.", "label": "ANTAGONIST", "metadata": []}
{"text": "Efficacy of the GluK1/<< AMPA receptor >> antagonist [[ LY293558 ]] against seizures and neuropathology in a soman-exposure model without pretreatment and its pharmacokinetics after intramuscular administration.", "label": "ANTAGONIST", "metadata": []}
{"text": "To determine if control of seizures and survival are still possible without pretreatment or immediate pharmacologic intervention, we studied the anticonvulsant efficacy of the << GluK1 >> (GluR5)/α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonist [[ (3S,4aR,6R,8aR)-6-[2-(1(2)H-tetrazole-5-yl)ethyl]decahydroisoquinoline-3-carboxylic acid ]] (LY293558) in rats that did not receive any treatment until 20 minutes after exposure to the nerve agent soman.", "label": "ANTAGONIST", "metadata": []}
{"text": "Cellular release of << AChE >> by SH-SY5Y is significantly enhanced by the muscarinic acetylcholine receptor (mAChR) agonists [[ carbachol ]] or muscarine, with the effect of carbachol blocked by the mAChR antagonist atropine.", "label": "INDIRECT-UPREGULATOR", "metadata": []}
{"text": "Cellular release of AChE by SH-SY5Y is significantly enhanced by the muscarinic acetylcholine receptor (<< mAChR >>) agonists [[ carbachol ]] or muscarine, with the effect of carbachol blocked by the mAChR antagonist atropine.", "label": "AGONIST", "metadata": []}
{"text": "It was reported previously that << FVII >> gene (F7) expression was up-regulated by [[ ribavirin ]] treatment in hepatitis C virus-infected haemophilia patients; however, its precise mechanism is still unknown.", "label": "INDIRECT-UPREGULATOR", "metadata": []}
{"text": "<< Ribavirin >> also enhanced recruitment of [[ CDK9 ]] (cyclin-dependent kinase 9) and AFF4 to F7.", "label": "INDIRECT-UPREGULATOR", "metadata": []}
{"text": "<< Ribavirin >> also enhanced recruitment of CDK9 ([[ cyclin-dependent kinase 9 ]]) and AFF4 to F7.", "label": "INDIRECT-UPREGULATOR", "metadata": []}
{"text": "<< Ribavirin >> also enhanced recruitment of CDK9 (cyclin-dependent kinase 9) and [[ AFF4 ]] to F7.", "label": "INDIRECT-UPREGULATOR", "metadata": []}
{"text": "These data suggest that << ribavirin >>-induced intracellular GTP depletion recruits a super elongation complex containing P-TEFb, [[ AFF4 ]] and ELL3, to F7, and modulates FVII mRNA transcription elongation.", "label": "INDIRECT-UPREGULATOR", "metadata": []}
{"text": "The potentiation of heteromeric KARs by << mGlu1 >> activation was attenuated by GDPβS, blocked by an inhibitor of phospholipase C or the calcium chelator [[ 1,2-bis(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid ]] (BAPTA), prolonged by the phosphatase inhibitor okadaic acid, but unaffected by the tyrosine kinase inhibitor lavendustin A.", "label": "INHIBITOR", "metadata": []}
{"text": "The potentiation of heteromeric << KARs >> by mGlu1 activation was attenuated by GDPβS, blocked by an inhibitor of phospholipase C or the calcium chelator 1,2-bis(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid (BAPTA), prolonged by the phosphatase inhibitor [[ okadaic acid ]], but unaffected by the tyrosine kinase inhibitor lavendustin A.", "label": "INHIBITOR", "metadata": []}
{"text": "Renal clearance of unbound anagliptin and unbound M1 far exceeded glomerular filtration rate, indicating active renal elimination: that might reflect the fact that << anagliptin >> may be a substrate of OAT1, [[ OAT3 ]], MDR1 and MRP2, and M1 a substrate of OAT3, BCRP, MRP2 and MRP4.", "label": "SUBSTRATE", "metadata": []}
{"text": "Data suggest that << bisphosphonates >> via modulation of the activity of small-GTPases induce apoptosis in neoplastic cells by DNA-CpG-demethylation and stimulation of [[ FAS ]]-expression.", "label": "INDIRECT-UPREGULATOR", "metadata": []}
{"text": "We found that << helenalin >> markedly induced endoplasmic reticulum (ER) stress-related genes, such as [[ regulated in development and DNA damage responses (REDD) 1 ]], activating transcription factor-4 (ATF4) and/or the CCAAT enhancer-binding protein-homologous protein (CHOP).", "label": "INDIRECT-UPREGULATOR", "metadata": []}
{"text": "We found that << helenalin >> markedly induced endoplasmic reticulum (ER) stress-related genes, such as regulated in development and DNA damage responses (REDD) 1, activating transcription factor-4 (ATF4) and/or the [[ CCAAT enhancer-binding protein-homologous protein ]] (CHOP).", "label": "INDIRECT-UPREGULATOR", "metadata": []}
{"text": "Heterologous expression of rCtr1 in HEK293 cells (HEK/<< rCtr1 >> cells) increased the uptake and cytotoxicity of [[ copper ]], oxaliplatin, cisplatin and carboplatin, in comparison to isogenic vector-transfected control cells.", "label": "SUBSTRATE", "metadata": []}
{"text": "Heterologous expression of rCtr1 in HEK293 cells (HEK/<< rCtr1 >> cells) increased the uptake and cytotoxicity of copper, [[ oxaliplatin ]], cisplatin and carboplatin, in comparison to isogenic vector-transfected control cells.", "label": "SUBSTRATE", "metadata": []}
{"text": "Examination of phosphorylation in << retinoblastoma (Rb) protein >>, we found an inhibitory effect by [[ glucosamine ]] at 20 and 50 mM.", "label": "INHIBITOR", "metadata": []}
{"text": "In contrast, << flunisolide >> was only metabolized via [[ CYP3A4 ]], with no significant turnover by CYP3A5 or CYP3A7.", "label": "SUBSTRATE", "metadata": []}
{"text": "Moreover, activation of the << ERK >> and CREB signaling pathway in the hippocampus might be involved in [[ METH ]]-induced spatial memory changes.", "label": "ACTIVATOR", "metadata": []}
{"text": "<< ISO >> is able to induce apoptosis through mitochondrial dysfunction and inhibition of [[ PI3K ]]/Akt signaling pathway in HepG2 cells, however, the effects of ISO on MAPK signaling pathways remain unknown.", "label": "INHIBITOR", "metadata": []}
{"text": "<< ISO >> significantly inhibited the levels of ERK1/2 kinase and increased the expression of JNK and p38 [[ kinases ]].", "label": "INDIRECT-UPREGULATOR", "metadata": []}
{"text": "Furthermore, U0126 (an ERK1/2 inhibitor) significantly enhanced the << ISO >>-induced the Bax/[[ Bcl-2 ]] ratio, the release of cytochrome c to the cytosol fraction, and the levels of cleaved caspase-3.", "label": "INDIRECT-UPREGULATOR", "metadata": []}
{"text": "These results demonstrated for the first time that << ISO >> induces apoptosis in HepG2 cells through inactivating ERK1/2 kinase and activating JNK and p38 [[ kinases ]], and ROS stimulated by ISO is able to activate the MAPK singaling pathway as the upstream signaling molecules.", "label": "ACTIVATOR", "metadata": []}
{"text": "Treatment with IMG and hyperoside resulted in significantly prolonged aPTT and PT and inhibition of the activities of thrombin and FXa, and << IMG >> or hyperoside inhibited production of [[ thrombin ]] and FXa in HUVECs.", "label": "INDIRECT-UPREGULATOR", "metadata": []}
{"text": "Whereas the addition of << apomorphine >> in the low micromolar range produced an irreversible activation of the channel, application of higher concentrations caused a reversible voltage-dependent inhibition of heterologously expressed [[ TRPA1 ]] channels, resulting from a reduction of single-channel open times.", "label": "INHIBITOR", "metadata": []}
{"text": "In addition, we provide evidence that << apomorphine >> also acts on endogenous TRPA1 in cultured dorsal root ganglion neurons from rats and in the enterochromaffin model cell line QGP-1, from which serotonin is released upon activation of [[ TRPA1 ]].", "label": "ACTIVATOR", "metadata": []}
{"text": "Dietary << carbohydrates >> increase [[ SCD-1 ]] gene expression in liver by sterol response element binding protein (SREBP)-1c-dependent and SREBP-1c -independent pathways.", "label": "INDIRECT-UPREGULATOR", "metadata": []}
{"text": "Moreover, << paclitaxel >>-induced [[ ERCC1 ]] protein and mRNA levels significantly decreased via the downregulation of p38 activity by either a p38 MAPK inhibitor SB202190 or p38 knockdown with specific small interfering RNA (siRNA).", "label": "INDIRECT-UPREGULATOR", "metadata": []}
{"text": "Furthermore, metformin was able to not only decrease the << paclitaxel >>-induced p38 [[ MAPK ]]-mediated ERCC1 expression, but also augment the cytotoxic effect induced by paclitaxel.", "label": "ACTIVATOR", "metadata": []}
{"text": "Furthermore, << metformin >> was able to not only decrease the paclitaxel-induced p38 MAPK-mediated [[ ERCC1 ]] expression, but also augment the cytotoxic effect induced by paclitaxel.", "label": "INDIRECT-DOWNREGULATOR", "metadata": []}
{"text": "This study was designed to test the hypothesis that << orlistat >> inhibits CESs with higher potency toward [[ CES1 ]] than CES2, a carboxylesterase with little lipase activity.", "label": "INHIBITOR", "metadata": []}
{"text": "This study was designed to test the hypothesis that << orlistat >> inhibits CESs with higher potency toward CES1 than [[ CES2 ]], a carboxylesterase with little lipase activity.", "label": "INHIBITOR", "metadata": []}
{"text": "This study was designed to test the hypothesis that << orlistat >> inhibits CESs with higher potency toward CES1 than CES2, a carboxylesterase with little [[ lipase ]] activity.", "label": "INHIBITOR", "metadata": []}
{"text": "We identified one compound, E235 << (N-(1-benzyl-piperidin-4-yl)-2-(4-fluoro-phenyl)-benzo[d]imidazo[2,1-b]thiazole-7-carboxamide) >>, that activated the ISR and dose-dependently increased levels of [[ ATF4 ]] in transformed cells.", "label": "INDIRECT-UPREGULATOR", "metadata": []}
{"text": "The mechanism revealed that << wogonin >> inhibited H2O2-induced phosphorylation of caveolin-1 ([[ cav-1 ]]) associating with the suppression of stabilization of VE-cadherin and β-catenin.", "label": "INHIBITOR", "metadata": []}
{"text": "Both CE and E(2) alone increased DNA synthesis and reduced apoptosis with activation of MAPK, << Akt >>, and p70S6K and up-regulation of antiapoptotic factors survivin, Bcl-2, and X-linked inhibitor of apoptosis protein, These effects could be completely blocked by [[ BZA ]].", "label": "INHIBITOR", "metadata": []}
{"text": "We used << nutlin-3 >>, a well-known disruptor of p53-[[ Mdm2 ]] interaction, to validate the specificity of the assay.", "label": "INHIBITOR", "metadata": []}
{"text": "<< Sal >> toxicity coincided with reduced pAkt level and its downstream effectors: pCREB, [[ pGSK-3β ]], Bcl-2 and neurotrophins GDNF, BDNF suggesting repressed PI3K/Akt signaling.", "label": "INDIRECT-DOWNREGULATOR", "metadata": []}
{"text": "<< Sal >> toxicity coincided with reduced pAkt level and its downstream effectors: pCREB, pGSK-3β, Bcl-2 and neurotrophins GDNF, BDNF suggesting repressed PI3K/[[ Akt ]] signaling.", "label": "INDIRECT-DOWNREGULATOR", "metadata": []}
{"text": "Increased urinary excretion of albumin, << hemopexin >>, transferrin and VDBP correlates with chronic sensitization to [[ gentamicin ]] nephrotoxicity in rats.", "label": "INDIRECT-UPREGULATOR", "metadata": []}
{"text": "Additionally, << DPEP >> suppressed the production of inflammatory cytokines, including [[ tumor necrosis factor-α ]] (TNF-α), interleukin (IL)-1β, and IL-6.", "label": "INDIRECT-DOWNREGULATOR", "metadata": []}
{"text": "<< DPEP >> inhibited LPS-induced phosphorylation of [[ ERK ]], JNK, and p38.", "label": "INHIBITOR", "metadata": []}
{"text": "<< Tetrahydropyrroloquinolinone >> type dual inhibitors of aromatase/[[ aldosterone synthase ]] as a novel strategy for breast cancer patients with elevated cardiovascular risks.", "label": "INHIBITOR", "metadata": []}
{"text": "Collectively, our data suggest that << TAM >> can repress the miR-200 family and induce EMT via the up-regulation of [[ c-Myc ]] in endometrial cancer cells.", "label": "UPREGULATOR", "metadata": []}
{"text": "Synthesis and dual biological effects of << hydroxycinnamoyl phenylalanyl >>/prolyl hydroxamic acid derivatives as [[ tyrosinase ]] inhibitor and antioxidant.", "label": "INHIBITOR", "metadata": []}
{"text": "In addition, derivatives of << caffeic acid >> and sinapic acid efficiently inhibited [[ tyrosinase ]] activity and reduced melanin content in melanocytes Mel-Ab cell.", "label": "INHIBITOR", "metadata": []}
{"text": "<< TAA >> also increased the numbers of ED2(+), cyclooxygenase-2(+), and [[ heme oxygenase-1 ]](+) liver cells, as well as the number of CD3(+) lymphocytes.", "label": "INDIRECT-DOWNREGULATOR", "metadata": []}
{"text": "Although << ICA >> greatly attenuates [[ ERG ]] inactivation by shifting its voltage dependence to more positive potentials, it enhances the rate and extent of EAG inactivation without altering its voltage dependence.", "label": "ACTIVATOR", "metadata": []}
{"text": "This shows that << CPT2 >> and CACT are crucial for mitochondrial [[ acylcarnitine ]] formation and export to the extracellular fluids in mFAOD.-Violante, S., IJlst, L., te Brinke, H., Tavares de Almeida, I., Wanders, R.", "label": "PRODUCT-OF", "metadata": []}
{"text": "This shows that CPT2 and << CACT >> are crucial for mitochondrial [[ acylcarnitine ]] formation and export to the extracellular fluids in mFAOD.-Violante, S., IJlst, L., te Brinke, H., Tavares de Almeida, I., Wanders, R.", "label": "PRODUCT-OF", "metadata": []}
{"text": "Commercially-available 5-HT2C agonists (CP 809101, Ro 60-0175, WAY 161503, mCPP, and 1-methylpsilocin), novel 4-phenyl-2-N,N-dimethyl-aminotetralin (<< PAT >>)-type [[ 5-HT2C ]] agonists (with 5-HT2A/2B antagonist activity), and antagonists selective for 5-HT2A (M100907), 5-HT2C (SB-242084), and 5-HT2B/2C (SB-206553) receptors attenuated the DOI-elicited-HTR.", "label": "AGONIST", "metadata": []}
{"text": "Methadone << N >>-demethylation in vitro is catalyzed by hepatic cytochrome P4502B6 (CYP2B6) and [[ CYP3A4 ]], but clinical disposition is often attributed to CYP3A4.", "label": "SUBSTRATE", "metadata": []}
{"text": "This investigation tested the hypothesis that << CYP2B6 >> is a prominent CYP isoform responsible for clinical [[ methadone ]] N-demethylation and clearance, using the in vivo mechanism-based CYP2B6 inhibitor ticlopidine, given orally for 4 days.", "label": "SUBSTRATE", "metadata": []}
{"text": "We found that treatment of both differentiated dopaminergic-like SH-SY5Y cells and rat midbrain slices with the dopamine D2 receptor (<< D2R >>) agonist, [[ quinpirole ]], triggered an increase in the expression of GDNF that was temporally preceded by an increase in the levels of zinc-finger protein 268 (Zif268), a DNA-binding transcription factor encoded by an immediate-early gene.", "label": "AGONIST", "metadata": []}
{"text": "Moreover, the << D2R >> inhibitor [[ raclopride ]] blocked the increase of both GDNF and Zif268 expression following potassium-evoked dopamine release in SH-SY5Y cells.", "label": "INHIBITOR", "metadata": []}
{"text": "<< LY294002 >>, a specific PI3K/AKT inhibitor, selectively activated the p38 MAPK [[ kinase ]] pathway and enhanced c-Jun phosphorylation, but did not activate JNK.", "label": "ACTIVATOR", "metadata": []}
{"text": "The pharmacological inhibitors << SB203580 >> ([[ p38 ]] inhibitor) and SP600125 (a JNK inhibitor) protected primary cultures of rat CGCs from LY294002-induced apoptosis.", "label": "INHIBITOR", "metadata": []}
{"text": "Cellular responses to DNA damage induced by << etoposide >> or doxorubicin include down-regulation of endogenous [[ supervillin ]] coincident with increases in p53.", "label": "INDIRECT-DOWNREGULATOR", "metadata": []}
{"text": "Number and area of preneoplastic foci positive for << glutathione S-transferase placental form >> (GST-P) were consistently higher in these groups than the sum of individual values in the groups treated with [[ HEP ]] or HCB alone.", "label": "INDIRECT-UPREGULATOR", "metadata": []}
{"text": "On the basis of these findings, we conclude that << HEP >> and HCB have additive and synergistic effects on the development of [[ GST-P ]]-positive foci and that higher risks are associated with a combination of residual organochlorine pesticides in foods than with individual residual organochlorine pesticides.", "label": "INDIRECT-UPREGULATOR", "metadata": []}
{"text": "The << Paeoniflorin >>-induced [[ HO-1 ]] expression was abrogated by Nrf2 siRNA.", "label": "INDIRECT-UPREGULATOR", "metadata": []}
{"text": "Aqueous << ethanol >> (80%) extract of lentil hulls exhibited high antioxidant and anti-inflammatory activities preferentially inhibiting 15-LOX (IC(50), 55 μg/ml), with moderate [[ COX-1 ]] (IC(50), 66 μg/ml) and COX-2 (IC(50), 119 μg/ml) inhibitory effects on the COX pathway, whereas faba bean hull extracts exerted relatively mild LOX inhibitory activity.", "label": "INHIBITOR", "metadata": []}
{"text": "<< Histidine decarboxylase >> (HDC) catalyses the formation of [[ histamine ]], a bioactive amine.", "label": "PRODUCT-OF", "metadata": []}
{"text": "Amino acid derived << quinazolines >> as Rock/[[ PKA ]] inhibitors.", "label": "INHIBITOR", "metadata": []}
{"text": "Although there was no change in the levels of insulin receptor (IR), Akt (protein kinase B) and glucose transporter-4 (GLUT4) messenger RNA, << BPA >> significantly decreased the IR, [[ Akt ]] and GLUT4 protein levels (both plasma membrane and cytosolic fraction) of the gastrocnemius muscle.", "label": "INDIRECT-DOWNREGULATOR", "metadata": []}
{"text": "Acute intoxication with << Cd >> was also followed by significantly decreased activity of the antioxidant defence system (superoxide dismutase ([[ SOD ]]), catalase (CAT), glutathione peroxidase (GSH-Px), glutathione reductase (GR), glutathione (GSH), and glutathione-S-transferase (GST)).", "label": "INHIBITOR", "metadata": []}
{"text": "Acute intoxication with << Cd >> was also followed by significantly decreased activity of the antioxidant defence system (superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase ([[ GSH-Px ]]), glutathione reductase (GR), glutathione (GSH), and glutathione-S-transferase (GST)).", "label": "INHIBITOR", "metadata": []}
{"text": "Acute intoxication with << Cd >> was also followed by significantly decreased activity of the antioxidant defence system (superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GSH-Px), glutathione reductase ([[ GR ]]), glutathione (GSH), and glutathione-S-transferase (GST)).", "label": "INHIBITOR", "metadata": []}
{"text": "Secondary point mutations in the Fms-like tyrosine kinase 3 (FLT3) tyrosine kinase domain (KD) are common causes of acquired clinical resistance to the << FLT3 >> inhibitors [[ AC220 ]] (quizartinib) and sorafenib.", "label": "INHIBITOR", "metadata": []}
{"text": "Ponatinib (<< AP24534 >>) is a [[ multikinase ]] inhibitor with in vitro and clinical activity in tyrosine kinase inhibitor (TKI)-resistant chronic myeloid leukemia, irrespective of BCR-ABL KD mutation.", "label": "INHIBITOR", "metadata": []}
{"text": "A one-pot domino synthesis and discovery of highly functionalized << dihydrobenzo[b]thiophenes >> as [[ AChE ]] inhibitors.", "label": "INHIBITOR", "metadata": []}
{"text": "N-acetylcysteine (NAC, 33 mM) and the << c-jun N-terminal kinase >> (JNK) inhibitor ([[ SP600125 ]], 33 μM) further decreased the viability in the presence of DEP (200 μg/ml) and 3.3% FCS.", "label": "INHIBITOR", "metadata": []}
{"text": "RATIONALE: << Histamine H3 receptor >> antagonists, such as [[ ABT-288 ]], have been shown to possess cognitive-enhancing and wakefulness-promoting effects.", "label": "ANTAGONIST", "metadata": []}
{"text": "CONCLUSIONS: The sum of these preclinical data, the first of their kind applied to H3 antagonists, indicates that << ABT-288 >> is unlikely to possess a high potential for abuse in the human population and suggests that [[ H3 ]] antagonists, as a class, are similar in this regard.", "label": "ANTAGONIST", "metadata": []}
{"text": "This methodology was subsequently used to assess the relative contribution of << OATP1B1 >> uptake in human hepatocytes for olmesartan (42%-62%), valsartan (28%-81%), rosuvastatin (64%-72%), [[ pitavastatin ]] (84%-98%) and lopinavir (64%-89%).", "label": "SUBSTRATE", "metadata": []}
{"text": "<< l-glutamine >> decreased plasma glucose, increased plasma and pancreatic [[ insulin ]], increased plasma and colonic active GLP-1 (7-36) amide secretion as well as decreased oxidative stress in streptozotocin-nicotinamide induced diabetic rats.", "label": "INDIRECT-UPREGULATOR", "metadata": []}
{"text": "<< Hinokitiol >> inhibited the phosphorylation of phospholipase C (PLC)γ2, protein kinase C (PKC), mitogen-activated protein kinases ([[ MAPKs ]]), and Akt in collagen-activated human platelets, and significantly reduced intracellular calcium mobilization and hydroxyl radical (OH) formation.", "label": "INHIBITOR", "metadata": []}
{"text": "Design, Synthesis, and Pharmacological Characterization of Novel << Endomorphin-1 >> Analogues as Extremely Potent [[ μ-Opioid ]] Agonists.", "label": "AGONIST", "metadata": []}
{"text": "Furthermore, no impact on cytokine release (i.e., on IL-10, IL-6, IL-12/23p40 and TNFα levels) was seen in LPS-stimulated human PBMCs, except with JWH-210 and << JWH-122 >> which caused a decrease of [[ TNFα ]] and IL-12/23p40.", "label": "INDIRECT-DOWNREGULATOR", "metadata": []}
{"text": "<< AlCl3 >> markedly reduced AA performance and activities of cytochrome c oxidase (COX) and acetylcholinesterase ([[ AChE ]]) in all regions.", "label": "INHIBITOR", "metadata": []}
{"text": "Synthesis of a DOTA (Gd(3+))-conjugate of << proton-pump >> inhibitor [[ pantoprazole ]] for gastric wall imaging studies.", "label": "INHIBITOR", "metadata": []}
{"text": "<< CYP3A5 >> carrier status had no influence on [[ midazolam ]] oral clearance or its inhibition by ketoconazole.", "label": "SUBSTRATE", "metadata": []}
{"text": "<< CYP3A4 >> and CYP3A5 metabolized [[ BDP ]] via hydroxylation ([M4] and [M6]) and dehydrogenation ([M5]) at similar rates; CYP3A7 did not metabolize BDP.", "label": "SUBSTRATE", "metadata": []}
{"text": "Results indicate that << CDM >> inhibits HSV-2 multiplication in epithelial cells and also increases [[ cytokine ]] production in macrophages, both important actions to the clearance of infecting virus in the mouse vagina.", "label": "INDIRECT-UPREGULATOR", "metadata": []}
{"text": "In DU-PM cells with acquired resistance to << elisidepsin >>, ErbB3 expression was decreased, while [[ Bcl2 ]] was increased.", "label": "INDIRECT-UPREGULATOR", "metadata": []}
{"text": "Administration of << bicuculline >>, a GABAA inhibitor, isolated a single response to [[ ω-agatoxin ]], which was characterized by a reduction in network activity.", "label": "INHIBITOR", "metadata": []}
{"text": "<< tert-Butylcarbamate >>-Containing [[ Histone Deacetylase ]] Inhibitors: Apoptosis Induction, Cytodifferentiation, and Antiproliferative Activities in Cancer Cells.", "label": "INHIBITOR", "metadata": []}
{"text": "Herein we report novel << pyrrole >>- and benzene-based hydroxamates (8, 10) and 2'-aminoanilides (9, 11) bearing the tert-butylcarbamate group at the CAP moiety as histone deacetylase ([[ HDAC ]]) inhibitors.", "label": "INHIBITOR", "metadata": []}
{"text": "Herein we report novel pyrrole- and benzene-based hydroxamates (8, 10) and << 2'-aminoanilides >> (9, 11) bearing the tert-butylcarbamate group at the CAP moiety as histone deacetylase ([[ HDAC ]]) inhibitors.", "label": "INHIBITOR", "metadata": []}
{"text": "Under NaCl and << sorbitol >> stresses, catalase ([[ CAT ]]) activity in wnk8 mutant was 1.92- and 3.7-times of that in Col-0, respectively.", "label": "ACTIVATOR", "metadata": []}
{"text": "<< Arsenic trioxide >> depletes cancer stem-like cells and inhibits repopulation of neurosphere derived from glioblastoma by downregulation of [[ Notch ]] pathway.", "label": "INHIBITOR", "metadata": []}
{"text": "In addition, << fisetin >> supplementation significantly reduced hepatic mRNA abundance of FAS, ATPCL and [[ G6Pase ]] compared to the control group.", "label": "INDIRECT-DOWNREGULATOR", "metadata": []}
{"text": "Quercetin and << rutin >> also increased [[ alkaline phosphatase ]] activity by about 150 and 240% and demonstrated mineralization up to 110 and 200% respectively as compared to control (which was considered as 100%).", "label": "ACTIVATOR", "metadata": []}
{"text": "<< Cytochrome P450 2E1 >> (CYP 450 2E1), activity was determined as hydroxylation of [[ aniline ]] in liver microsomes.", "label": "SUBSTRATE", "metadata": []}
{"text": "Cytochrome P450 2E1 (<< CYP 450 2E1 >>), activity was determined as hydroxylation of [[ aniline ]] in liver microsomes.", "label": "SUBSTRATE", "metadata": []}
{"text": "Oxysterol-dependent NOX1 activation, as well as << interleukin >> synthesis, were completely prevented by Cannonau red wine extract that contains an abundant phenolic fraction, in particular [[ phenolic acids ]] and flavonoids.", "label": "INDIRECT-DOWNREGULATOR", "metadata": []}
{"text": "Conversely, cell pre-treatment with Vermentino white wine extract with smaller phenolic fraction showed only a partial NOX1 down-regulation and was ineffective in << interleukin >> synthesis induced by dietary [[ oxysterols ]].", "label": "INDIRECT-UPREGULATOR", "metadata": []}
{"text": "<< Arsenic >> inhibits autophagic flux activating the Nrf2-[[ Keap1 ]] pathway in a p62-dependent manner.", "label": "ACTIVATOR", "metadata": []}
{"text": "<< Arsenic >> deregulates the autophagic pathway through blockage of autophagic flux, resulting in accumulation of autophagosomes and sequestration of p62, [[ Keap1 ]], and LC3.", "label": "INDIRECT-DOWNREGULATOR", "metadata": []}
{"text": "Conversely, ovarian PRA and PRB were positively regulated by ethanol and ethanol-melatonin combination, whereas << PRA >> was down-regulated in the uterus and oviduct after [[ ethanol ]] consumption.", "label": "INDIRECT-DOWNREGULATOR", "metadata": []}
{"text": "While imatinib was unable to block cisplatin-induced DNA damage and damage response, such as the upregulation of p53, << imatinib >> inhibited the cisplatin-induced nuclear accumulation of [[ c-Abl ]]/TAp73 and the subsequent downregulation of TAp63 and upregulation of Bax, thereby abrogating oocyte cell death.", "label": "INDIRECT-DOWNREGULATOR", "metadata": []}
{"text": "Surprisingly, the conditional deletion of Trp63, but not ΔNp63, in oocytes inhibited apoptosis, as well as the accumulation of << c-Abl >> and TAp73 caused by [[ cisplatin ]].", "label": "INDIRECT-UPREGULATOR", "metadata": []}
{"text": "Surprisingly, the conditional deletion of Trp63, but not ΔNp63, in oocytes inhibited apoptosis, as well as the accumulation of c-Abl and << TAp73 >> caused by [[ cisplatin ]].", "label": "INDIRECT-UPREGULATOR", "metadata": []}
{"text": "Our findings indicate that << imatinib >> protects oocytes from cisplatin-induced cell death by inhibiting [[ c-Abl ]] kinase, which would otherwise activate TAp73-BAX-mediated apoptosis.", "label": "INHIBITOR", "metadata": []}
{"text": "Among the possible transporters involved in the uptake of << Cd(2+) >> and Mn(2+), the expression of [[ ZIP8 ]] (Zrt-, Irt-related protein 8), encoded by Slc39a8, showed a marked suppression in both RBL-Cdr and RBL-Mnr cells.", "label": "SUBSTRATE", "metadata": []}
{"text": "Using recombinant << UGT2B10 >>, we found that it catalyzes the N-glucuronidation of [[ amitriptyline ]], imipramine, ketotifen, pizotifen, olanzapine, diphenhydramine, tamoxifen, ketoconazole and midazolam.", "label": "SUBSTRATE", "metadata": []}
{"text": "Using recombinant << UGT2B10 >>, we found that it catalyzes the N-glucuronidation of amitriptyline, imipramine, ketotifen, pizotifen, [[ olanzapine ]], diphenhydramine, tamoxifen, ketoconazole and midazolam.", "label": "SUBSTRATE", "metadata": []}
{"text": "Using recombinant << UGT2B10 >>, we found that it catalyzes the N-glucuronidation of amitriptyline, imipramine, ketotifen, pizotifen, olanzapine, diphenhydramine, tamoxifen, ketoconazole and [[ midazolam ]].", "label": "SUBSTRATE", "metadata": []}
{"text": "This group of drugs contains secondary or primary amines, and these results suggest that << UGT2B10 >> preferably conjugates [[ tertiary amines ]].", "label": "SUBSTRATE", "metadata": []}
{"text": "Kinetic analyses revealed that the affinity and clearance of UGT2B10 for amitriptyline, imipramine, and << diphenhydramine >> are significantly higher than the corresponding values of [[ UGT1A4 ]] and UGT1A3, although the Vmax values of UGT1A4 toward these drugs are considerably higher.", "label": "SUBSTRATE", "metadata": []}
{"text": "In conclusion, this study expands the understanding of the substrate specificity of << UGT2B10 >>, highlighting its preference for [[ tertiary amines ]] with higher affinities and clearance values than those of UGT1A4 and UGT1A3.", "label": "SUBSTRATE", "metadata": []}
{"text": "Treatment with << CAPE >> decreased protein abundance of Akt, Akt1, Akt2, Akt3, phospho-Akt Ser473, phospho-Akt Thr 308, GSK3β, FOXO1, FOXO3a, phospho-FOXO1 Thr24, phospho-FoxO3a Thr32, [[ NF-κB ]], phospho-NF-κB Ser536, Rb, phospho-Rb Ser807/811, Skp2, and cyclin D1, but increased cell cycle inhibitor p27Kip.", "label": "INDIRECT-DOWNREGULATOR", "metadata": []}
{"text": "Treatment with << CAPE >> decreased protein abundance of Akt, Akt1, Akt2, Akt3, phospho-Akt Ser473, phospho-Akt Thr 308, GSK3β, FOXO1, FOXO3a, phospho-FOXO1 Thr24, phospho-FoxO3a Thr32, NF-κB, phospho-NF-κB Ser536, Rb, [[ phospho-Rb ]] Ser807/811, Skp2, and cyclin D1, but increased cell cycle inhibitor p27Kip.", "label": "INDIRECT-DOWNREGULATOR", "metadata": []}
{"text": "Although << fisetin >> greatly increases the stability of both [[ Nrf2 ]] and ATF4, only the effect on ATF4 is dependent on protein kinase activity.", "label": "INDIRECT-UPREGULATOR", "metadata": []}
{"text": "Cynomolgus FMO1, FMO2, FMO3, and FMO5 metabolized benzydamine, and << FMO1 >>/FMO3 and FMO3 also metabolized [[ methimazole ]] and trimethylamine, respectively.", "label": "SUBSTRATE", "metadata": []}
{"text": "Cynomolgus FMO1, FMO2, FMO3, and FMO5 metabolized benzydamine, and FMO1/FMO3 and << FMO3 >> also metabolized methimazole and [[ trimethylamine ]], respectively.", "label": "SUBSTRATE", "metadata": []}
{"text": "<< Cynomolgus FMO6 >> metabolized [[ benzydamine ]] only slightly, but minimal expression of FMO6 in all tissue precludes the importance of FMO6 in drug metabolism, unlike cynomolgus FMO1, FMO2, FMO3, and FMO5 which were all functional.", "label": "SUBSTRATE", "metadata": []}
{"text": "There was also an increase in << γ-GCS >> and HO-1 levels in [[ calycopterin ]] pretreated cells.", "label": "INDIRECT-UPREGULATOR", "metadata": []}
{"text": "There was also an increase in γ-GCS and << HO-1 >> levels in [[ calycopterin ]] pretreated cells.", "label": "INDIRECT-UPREGULATOR", "metadata": []}
{"text": "Activation of << STAT3 >>, which is phosphorylated by the IL-6 signaling pathways and thus is necessary for Th17 differentiation, was strongly stimulated by [[ I3S ]] and TCDD.", "label": "ACTIVATOR", "metadata": []}
{"text": "Phosphorylation of << c-Src >>, which was shown to be activated by AhR ligands, was also increased by [[ I3S ]] and TCDD, and blocking of c-Src activity by 4-amino-5-(4-chlorophenyl)-7-(t-butyl) pyrazolo[3,4-d]pyrimidine (PP2) inhibited phosphorylation of both c-Src and STAT3, raising a possibility that stimulatory activities of I3S and TCDD on Th17 differentiation could be exerted via increased phosphorylation of c-Src, which in turn stimulates STAT3 activation.", "label": "ACTIVATOR", "metadata": []}
{"text": "Inhibition of MCF-7 cell growth by the selective calmodulin antagonists W-13 and W-12 is consistent with a role for << calmodulin >> antagonism in the broad growth-inhibitory properties of [[ pimozide ]].", "label": "INHIBITOR", "metadata": []}
{"text": "Inhibition of MCF-7 cell growth by the selective << calmodulin >> antagonists W-13 and [[ W-12 ]] is consistent with a role for calmodulin antagonism in the broad growth-inhibitory properties of pimozide.", "label": "ANTAGONIST", "metadata": []}
{"text": "After << loperamide >> administration ACTH levels fell to a nadir of 135 +/- 76 pg/ml, and then CRH was still able to induce an [[ ACTH ]] increase; the pattern of ACTH response to CRH was slightly delayed.", "label": "INDIRECT-UPREGULATOR", "metadata": []}
{"text": "<< Ambenonium >> is known to be an inhibitor of acetylcholinesterase, and recent data have shown this drug to antagonize [[ muscarinic receptors ]] as well.", "label": "ANTAGONIST", "metadata": []}
{"text": "Ambenonium was a less potent antagonist of tissue responses to acetylcholine, and the underestimation in the pKB (as compared to that obtained with bethanechol) could be eliminated by prior treatment of tissues with the << acetylcholinesterase >> inhibitor [[ neostigmine ]].", "label": "INHIBITOR", "metadata": []}
{"text": "These data suggested that << ambenonium >> had a dual effect on tissue responses to acetylcholine-producing potentiation by blockade of acetylcholinesterase and concomitant antagonism by blockade of [[ muscarinic receptors ]].", "label": "ANTAGONIST", "metadata": []}
{"text": "However, betaxolol produces less systemic beta 2- and possibly << beta 1-adrenergic receptor >> blockade than either [[ timolol ]] or levobunolol.", "label": "INHIBITOR", "metadata": []}
{"text": "<< Tyrosinase >> catalyzes an unusual oxidative decarboxylation of [[ 3,4-dihydroxymandelate ]].", "label": "SUBSTRATE", "metadata": []}
{"text": "The activation of human [Glu1]plasminogen [( Glu1]Pg) by human recombinant (rec) two-chain << tissue plasminogen activator >> (t-PA) is inhibited by Cl-, at physiological concentrations, and stimulated by [[ epsilon-aminocaproic acid ]] (EACA), as well as fibrin(ogen).", "label": "ACTIVATOR", "metadata": []}
{"text": "Sodium-dependent norepinephrine-induced currents in << norepinephrine-transporter >>-transfected HEK-293 cells blocked by [[ cocaine ]] and antidepressants.", "label": "INHIBITOR", "metadata": []}
{"text": "Moreover, the production of << TXB2 >> during whole blood clotting was assessed as an index of the [[ cyclooxygenase ]] activity of platelet PGHS-1 ex vivo.", "label": "PRODUCT-OF", "metadata": []}
{"text": "Indomethacin, << piroxicam >>, and sulindac sulfide were found to preferentially inhibit [[ PGHS-1 ]].", "label": "INHIBITOR", "metadata": []}
{"text": "In addition several ligands known to act as agonists at either 5-HT2A or << 5-HT2C >> receptors including [[ 1-m-chlorophenylpiperazine ]] (m-CPP), Ru 24969, MK 212 and SCH 23390 were also agonists in rat fundus whilst sumatriptan, renzapride and 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) were very weak or inactive.", "label": "AGONIST", "metadata": []}
{"text": "After CFVs were observed for 30 min, the animals were randomly divided in four groups: 5 animals received via a small catheter (26G) placed proximally to the stenosis, an intra-arterial infusion of human recombinant FVIIai (0.1 mg/kg/min for 10 min); 9 animals received AP-1, a monoclonal antibody against rabbit TF (0.1 mg/kg i.v. bolus); 7 animals received ridogrel, a dual thromboxane A2 synthetase inhibitor and thromboxane A2 receptor antagonist (10 mg/kg i.v. bolus); finally, 8 rabbits received << aurintrycarboxilic acid >> (ATA), an inhibitor of platelet [[ glycoprotein Ib ]]/von Willebrand factor interaction (10 mg/kg i.v. bolus).", "label": "INHIBITOR", "metadata": []}
{"text": "These events are stimulated by NE and by guanethidine, an << hNET >> substrate, and they are blocked by [[ cocaine ]] and the antidepressant desipramine.", "label": "INHIBITOR", "metadata": []}
{"text": "Amezinium and << debrisoquine >> are substrates of uptake1 and potent inhibitors of [[ monoamine oxidase ]] in perfused lungs of rats.", "label": "INHIBITOR", "metadata": []}
{"text": "The results when considered with previous reports in the literature show that amezinium is about 1000 times more potent and << debrisoquine >> is about 20 times more potent for [[ MAO ]] inhibition in rat lungs than in tissue homogenates, and the reason for their high potencies in the intact lungs is transport and accumulation of the drugs in the pulmonary endothelial cells by uptake1.", "label": "INHIBITOR", "metadata": []}
{"text": "We have investigated the effects of << CP-99,994 >> [(+)-(2s,3s)-3-(2-methoxybenzylamino)-2-phenylpiperidine], a [[ tachykinin NK1 receptor ]] antagonist, HOE 140 (D-Arg[Hyp3,Thi5,D-Tic7,Oic8]bradykinin), a bradykinin B2 receptor antagonist, and ketotifen (4-(1-methyl-4-piperidylidene)4 H-benzo[4,5]cycloheptal[1,2-b]thiophen-10(9H)-one hydrogen fumarate), a histamine H1 receptor antagonist with mast cell-stabilizing properties, on microvascular leakage induced by gaseous formaldehyde.", "label": "ANTAGONIST", "metadata": []}
{"text": "We have investigated the effects of CP-99,994 [(+)-(2s,3s)-3-(2-methoxybenzylamino)-2-phenylpiperidine], a tachykinin NK1 receptor antagonist, HOE 140 (D-Arg[Hyp3,Thi5,D-Tic7,Oic8]bradykinin), a bradykinin B2 receptor antagonist, and << ketotifen >> (4-(1-methyl-4-piperidylidene)4 H-benzo[4,5]cycloheptal[1,2-b]thiophen-10(9H)-one hydrogen fumarate), a [[ histamine H1 receptor ]] antagonist with mast cell-stabilizing properties, on microvascular leakage induced by gaseous formaldehyde.", "label": "ANTAGONIST", "metadata": []}
{"text": "A 59-year-old female suffering from malignant lymphoma developed therapy-related acute myeloblastic leukemia (t-AML) after chemotherapy consisting of treatment with << DNA-topoisomerase II >> inhibitors, [[ etoposide ]] and mitoxantrone, and an alkylating agent, cyclophosphamide.", "label": "INHIBITOR", "metadata": []}
{"text": "Unlike the nonselective << MAO >> inhibitors, [[ selegiline ]] does not significantly potentiate tyramine-induced hypertension (the 'cheese effect') at the dosages (5 to 10 mg daily) used for the treatment of Parkinson's disease.", "label": "INHIBITOR", "metadata": []}
{"text": "Similarly, << salicylic acid >> (3 mM) reduced [[ CFTR ]] Cl- current by 50+/-8% with an apparent reduction in single channel amplitude from 1.08+/-0.03 pA to 0.48+/-0.06 pA (n = 4).", "label": "INHIBITOR", "metadata": []}
{"text": "Based on these results, we conclude that the NSAIDs ibuprofen and << salicylic acid >> inhibit cAMP-mediated Cl- secretion in human colonic and airway epithelia via a direct inhibition of CFTR [[ Cl- channels ]] as well as basolateral membrane K+ channels.", "label": "INHIBITOR", "metadata": []}
{"text": "Additional neuroendocrine experiments in a parallel group of rats revealed a dose-related increase in plasma prolactin and << ACTH >> levels after i.v. [[ mCPP ]], pointing to a general state of arousal in these mCPP-treated animals.", "label": "INDIRECT-UPREGULATOR", "metadata": []}
{"text": "These data indicate that mixed 5-HT1/5-HT2 receptor antagonists such as pizotifen and methysergide, and mixed 5-HT and catecholamine antagonists such as mianserin and mirtazapine are more potent antagonists of mCPP-induced behavioural inhibition in rats than the more selective 5-HT2A/<< 5-HT2C >> antagonist [[ ritanserin ]].", "label": "ANTAGONIST", "metadata": []}
{"text": "State-dependent << cocaine >> block of [[ sodium channel ]] isoforms, chimeras, and channels coexpressed with the beta1 subunit.", "label": "INHIBITOR", "metadata": []}
{"text": "<< Cocaine >> block of hH1 channels was greater than block of mu1 channels at voltages between -120 mV and -90 mV, suggesting that greater steady-state inactivation of [[ hH1 channels ]] in this voltage range makes them more susceptible to cocaine block.", "label": "INHIBITOR", "metadata": []}
